Our vision and goal is personalized high precision medicine in oncology by monitoring exposition and disposition as determinants of individualized cancer treatment in a longitudinal manner. This, in turn, is based on and/or leads into the and metastasis formation and thus to the understanding of incurable cancer.
How we want to perform longitudinal monitoring exactly:
Patient evaluations, molecular analysis, translational and virtual model systems as well as the integration of digital data science and bioinformatics are represented in all three columns.
Certain oncological diseases are particularly well suited for this research area. Therefore, the following table lists index diseases that are mainly examined. In addition, all other neoplasms are also used as models if required.